In which rheumatic diseases is IVIG indicated

In which rheumatic diseases is IVIG indicated? How might it work in these diseases?

  • • Autoimmune thrombocytopenia: Fc portion of IVIG binds the Fc receptor on reticuloendothelial cells blocking the removal of antibody-coated cells.
  • • Kawasaki disease: IVIG reduces expression of adhesion molecules on endothelial cells, binds cytokines that cause inflammation, reduces number of activated T cells, and binds staphylococcal toxin superantigens.
  • • Dermatomyositis and polymyositis: the Fc portion of IVIG can bind to C3b and C4b, decreasing complement activation.
  • • Chronic inflammatory demyelinating polyneuropathy.
  • • Antiphospholipid antibody syndrome (off-label).
  • • Autoimmune hemolytic anemia and neutropenia (off-label).
    • Other proposed mechanisms that may explain IVIG effectiveness in autoimmune diseases include:
    • • Antiidiotypic antibodies bind surface immunoglobulin on B cells preventing binding to target autoantigen.
    • • Saturation of neonatal Fc receptor resulting in accelerated degradation of pathogenic IgG.
    • • Sialylated fraction of IVIG (5% of total IVIG) binds to the protein, DC-SIGN, on dendritic cells resulting in enhanced expression of inhibitory FcγRs (FcγRIIb) on effector macrophages which can attenuate inflammation.
    • • Others: enhancement of Treg function, inhibition of dendritic cells.

Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

Scroll to Top